Items where Author is "Paulus, E."

Article

Schlitt, H. and Kaiser, G. and Richter, N. and Heyne, N. and Rauchfuss, F. and Neuhaus, P. and Schemmer, P. and Fischer, L. and Paulus, E. and Mertens, M. and Sterneck, M. (2013) The PROTECT Study: 35 Months of Everolimus Monotherapy vs. Calcineurin Inhibitor-Based Therapy Showed To Be a Safe Alternative with Superior Renal Function in Liver Transplant Recipients. AMERICAN JOURNAL OF TRANSPLANTATION, 13 (Suppl5). p. 130. ISSN 1600-6135, 1600-6143

Other

De Simone, P. and Fischer, L. and Kaiser, G. and Jonas, S. and Heise, M. and Schemmer, P. and Pascher, A. and Schlitt, H. and Paulus, E. and Mertens, M. and Duvoux, C. (2013) EARLY EVEROLIMUS PLUS REDUCED TACROLIMUS VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS RESULTS IN SUPERIOR RENAL FUNCTION AND SUSTAINS OVER 24 MONTHS: RESULTS OF A RANDOMIZED TRIAL. WILEY-BLACKWELL, HOBOKEN.

Fung, J. and Fischer, L. and Kaiser, G. and Jonas, S. and Heise, M. and Schemmer, P. and Pascher, A. and Schlitt, H. and Paulus, E. and Mertens, M. and Nevens, F. (2013) EVEROLIMUS PLUS REDUCED TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS ACHIEVES COMPARABLE OVERALL EFFICACY WITH FEWER BIOPSY-PROVEN ACUTE REJECTIONS VERSUS STANDARD TACROLIMUS: 24-MONTH RESULTS OF A RANDOMIZED TRIAL. WILEY-BLACKWELL, HOBOKEN.

Schlitt, H. and Kaiser, G. and Richter, N. and Heyne, N. and Rauchfuss, F. and Pascher, A. and Schemmer, P. and Fischer, L. and Paulus, E. and Mertens, M. and Sterneck, M. (2013) THE PROTECT STUDY: EFFECT OF 35 MONTH EVEROLIMUS MONOTHERAPY VS. CALCINEURIN INHIBITOR-BASED THERAPY ON EFFICACY AND RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS. WILEY-BLACKWELL, HOBOKEN.